Delivery Order SPE2DB20D3505-SPE2DB25FU0Y2

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,240.45, is for the delivery of 1,000 units of the drug Propranolol 10 mg tablet. The contract is a firm fixed-price Delivery Order, with a completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) provides the Defense Logistics Agency (DLA) Troop Support Medical with 1,000 units of the prescription drug Propranolol 20 mg tablets. The $1,163.59 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen, which serves as the primary vehicle for the company to supply a range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Propranolol 10 mg tablets. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The current delivery order has a ceiling value of $2,204.81 and a completion date of September 5,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,178.53 Firm Fixed Price delivery order contract is for the supply of 4,566,166,582 units of Propranolol 20 mg tablets. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.09 Delivery Order contract is for the delivery of 4,566,705,153 units of Propranolol ER 80 mg capsules. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,337.51, is for the delivery of 100 units of Propranolol ER 80 mg capsules. It is a firm-fixed-price delivery order contract with a completion date of February 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.05 firm fixed-price delivery order is for the supply of 4,566,571,030 units of the prescription drug propranolol 10 mg tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, with ID SPE2DB22D2108|SPE2DB24FU4FE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.08 firm fixed-price delivery order is for the supply of 4,564,911,939 units of the drug Propranolol 20 mg tablets. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,088.92 firm fixed-price delivery order is for the supply of 100 units of 60 mg Propranolol ER capsules, a cardiovascular medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,490.97 firm fixed-price delivery order is for the supply of propranolol ER 80 mg capsules, with a completion date of December 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU0Y2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,346.55, is for the delivery of propranolol 10 mg tablets to support federal healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/30/25, 10:10 AM